October 3, 2024
TOPLINE: Faricimab demonstrated a greater reduction in hard exudates than aflibercept in patients with diabetic macular edema (DME), according to research presented at EURETINA 2024. Hard […]
October 3, 2024
TOPLINE: Home-based phototherapy for plaque and guttate psoriasis is as effective as office-based phototherapy, according to results of the randomized Light Treatment Effectiveness study. METHODOLOGY: The […]
October 2, 2024
TOPLINE: Adjuvant chemotherapy after removal of the affected eye improves outcomes in children with unilateral retinoblastoma who have high-risk histopathologic features that predispose them to metastases […]
October 2, 2024
TOPLINE: Over 90% of patients with symptoms of bronchitis, sinus infections, sore throats, colds or flu, or diarrhea expect antibiotic prescriptions. Visiting a public clinic, lower […]
October 1, 2024
TOPLINE: National foot screening programmes for patients with diabetes began in 2004 in England and 2006 in Scotland. The number and quality of studies to support […]
October 1, 2024
TOPLINE: Women with hyperandrogenic polycystic ovary syndrome (PCOS) have lower pregnancy (29.9%) and live birth rates (20.1%) than those with nonhyperandrogenic PCOS (40.2% and 33.1%, respectively). […]
October 1, 2024
TOPLINE: For patients with type 1 diabetes (T1D), a positive test or hospitalization for COVID-19 increases the risk of developing hypertension, chronic kidney disease (CKD), and […]
October 1, 2024
TOPLINE: A unique glycosylation signature on circulating antibodies is detectable in blood up to 6 years before a diagnosis of Crohn’s disease and could serve as […]
September 30, 2024
TOPLINE: A new epigenetic assay is able to stratify patients with Barrett’s esophagus into lower-risk and higher-risk categories for progression to high-grade dysplasia or esophageal adenocarcinoma […]